Anna Maria Storniolo

Also affiliated with Indiana University School of Medicine, Indiana University – Purdue University Indianapolis

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

2.4Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis

Nature Cancer(2022)10.1038/s43018-022-00491-x

Top 9%

2.4DataRank

Top 9%114 citations

Toshinori Hinoue, Gregory Wheeler, Benjamin Kelly, Ana C. Garrido-Castro, Tomás Pascual +53 more

Papers

Driven by 18 papers — median percentile 91. Top paper: “A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART, SWOG S1609)”.

A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART, SWOG S1609)

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2182

N/A

3.8DataRank · unranked

125 citations

Megan Othus, Sandip Pravin Patel, Kathy D. Miller, Rashmi Chugh, Scott M. Schuetze +23 more

Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis

Nature Cancer(2022)10.1038/s43018-022-00491-x

Top 9%

2.4DataRank

Top 9%114 citations

Toshinori Hinoue, Gregory Wheeler, Benjamin Kelly, Ana C. Garrido-Castro, Tomás Pascual +53 more

TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer

UNC Libraries(2020)10.17615/yrss-qx89

N/A

0DataRank · unranked

0 citations

Charles M. Perou, Madlyn Ferraro, Mothaffar F. Rimawi, Wing‐Keung Chiu, Antonio C. Wolff +15 more

The Effects of Lifetime Estrogen Exposure on Breast Epigenetic Age

Cancer Epidemiology Biomarkers & Prevention(2021)10.1158/1055-9965.epi-20-1297

N/A

0DataRank · unranked

31 citations

Jill E. Henry, Anna Maria Storniolo, Steve Horvath, Patricia A. Ganz, Mary E. Sehl

Initial Phase I Safety Study of Gedatolisib plus Cofetuzumab Pelidotin for Patients with Metastatic Triple-Negative Breast Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3078

N/A

0DataRank · unranked

29 citations

Jeffrey P. Solzak, Chao J. Wang, Bradley A. Hancock, Sunil Badve, Sandra K. Althouse +6 more

Automated lesion detection of breast cancer in [18F] FDG PET/CT using a novel AI-Based workflow

Frontiers in Oncology(2022)10.3389/fonc.2022.1007874

N/A

0DataRank · unranked

13 citations

Steven P. Rowe, Vered Stearns, Roisín M. Connolly, Christos Vaklavas, Minetta C. Liu +5 more

Towards defining morphologic parameters of normal parous and nulliparous breast tissues by artificial intelligence

Breast Cancer Research(2022)10.1186/s13058-022-01541-z

N/A

0DataRank · unranked

11 citations

Thomas de Bel, Derek C. Radisky, Jennifer M. Kachergus, E. Aubrey Thompson, Amy C. Degnim +18 more

Serum hormone levels and normal breast histology among premenopausal women

Breast Cancer Research and Treatment(2022)10.1007/s10549-022-06600-9

N/A

0DataRank · unranked

3 citations

Thomas de Bel, Michael G. Heckman, Launia J. White, Joshua Ogony, Melody Stallings‐Mann +13 more

Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms

Research Square(2022)10.21203/rs.3.rs-1315678/v1

N/A

0DataRank · unranked

5 citations

Julie A. Douglas, Robert M. Miller, Kelley M. Kidwell, Christina L. Gersch, Zeruesenay Desta +7 more

Multiplatform Analysis of Primary and Metastatic Breast Tumors from the AURORA US Network identifies microenvironment and epigenetics drivers of metastasis

Research Square(2022)10.21203/rs.3.rs-1221704/v1

N/A

0DataRank · unranked

2 citations

Susana García‐Recio, Toshinori Hinoue4, Gregory Wheeler, Benjamin Kelly, Ana C. Garrido-Castro +49 more

Towards Defining Morphologic Parameters of Normal Parous and Nulliparous Breast Tissues by Artificial Intelligence

Research Square(2022)10.21203/rs.3.rs-1359557/v1

N/A

0DataRank · unranked

0 citations

Thomas de Bel, Derek C. Radisky, Jennifer M. Kachergus, E. Aubrey Thompson, Amy C. Degnim +18 more

Polypharmacy and premature aromatase inhibitor (AI) discontinuation in older women with breast cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6568

N/A

0DataRank · unranked

0 citations

Kelley M. Kidwell, Vered Stearns, Daniel F. Hayes, Anna Maria Storniolo, N. Lynn Henry +1 more

Exploring homologous recombination deficiency thresholds for predicting response to platinum-based treatment in triple negative breast cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.525

N/A

0DataRank · unranked

0 citations

Lauren Lenz, Elizabeth S. Cogan, Erica L. Mayer, Virginia Kaklamani, Vered Stearns +15 more

Data from A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART, SWOG S1609)

(2023)10.1158/1078-0432.c.6530837

N/A

0DataRank · unranked

0 citations

Megan Othus, Sandip Pravin Patel, Kathy D. Miller, Rashmi Chugh, Scott M. Schuetze +23 more

Data from Initial Phase I Safety Study of Gedatolisib plus Cofetuzumab Pelidotin for Patients with Metastatic Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6532511.v1

N/A

0DataRank · unranked

0 citations

Jeffrey P. Solzak, Chao J. Wang, Bradley A. Hancock, Sunil Badve, Sandra K. Althouse +6 more

Polygenic risk score for the prediction of breast cancer is related to lesser terminal duct lobular unit involution of the breast

npj Breast Cancer(2020)10.1038/s41523-020-00184-7

N/A

0DataRank · unranked

22 citations

Hannah Oh, Andriy Derkach, Joshua N. Sampson, Brian L. Sprague, Pamela M. Vacek +19 more

Data from Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor Therapy

(2023)10.1158/1078-0432.c.6523959

N/A

0DataRank · unranked

0 citations

Amanda L. Blackford, Anne Nguyen, Todd C. Skaar, Santosh Philips, Steffi Oesterreich +12 more

TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases

UNC Libraries(2020)10.17615/bgrr-9v25

N/A

0DataRank · unranked

0 citations

Anna Maria Storniolo, Vered Stearns, Vandana G. Abramson, Joel S. Parker, Catherine Van Poznak +19 more

Anna Maria Storniolo

Indexed papers

Top data-sharing exemplar

Papers